Ayala Pharmaceuticals Inc (ADXS)

[Meishairwin]

Mypekeispooped, you say, "Once the IND is filed, Sellas takes over development which could be an enormous cost saver to Advaxis."

To clarify, the SELLAS agreement only covers the combination of Axal and their WT1 therapy, NOT to anything else. Thus, SELLAS does the clinical work, but not for Lm or Axal in general.

The SELLAS deal is very focused and limited, as it should be for the money involved. ADXS is still free to license Lm to others for any other combos or indications. Dan is a very shrewd deal-maker....